The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Differences in cancer incidence by broad ethnic group in England, 2013–2017
Open accessAbstract
Background: Cancer incidence variation between population groups can inform public health and cancer services. Previous studies have shown cancer incidence rates vary by ethnic group in England. Since their publication, the completeness of ethnicity recording in cancer data has improved, and relevant inequalities (e.g. risk factor prevalence and healthcare access) may have changed. Methods: Age-standardised incidence rates were calculated for Asian, Black, Mixed/Multiple and White ethnic groups in England in 2013–2017, using almost 3 million diagnoses across 31 cancer sites. Rate ratios were calculated with the White ethnic group as reference. Sensitivity analyses used imputed ethnicity for cases with missing data and perturbed population estimates. Results: Incidence rates for most cancer sites and ethnic group and sex combinations were lower in non-White minority ethnic groups compared with the corresponding White group, with particularly low rate ratios (below 0.5) for melanoma skin cancer and some smoking-related cancers (lung, bladder and oesophageal cancers). Exceptions included prostate cancer (2.1 times higher in males of Black ethnicity), myeloma (2.7–3.0 times higher in people of Black ethnicity), several gastrointestinal cancers (1.1–1.9 times higher in people of Black ethnicity, 1.4–2.2 times higher in people of Asian ethnicity), Hodgkin lymphoma (1.1 times higher in males of Asian ethnicity, 1.3 times higher in males of Black ethnicity) and thyroid cancers (1.4 times higher in people of Asian ethnicity, 1.2 times higher in people of Black ethnicity). Sensitivity analyses did not materially alter these results (rate ratios changed by a maximum of 12 percentage points, the direction and significance of results were unchanged in all but two cancer site/sex/ethnic group combinations). Conclusions: People of non-White minority ethnicity in England generally have lower cancer risk than the White population, though there are a number of notable exceptions. These results should galvanise efforts to better understand the reasons for this variation, and the possible impact on cancer services, patient experiences and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Yet, multiple sources indicate that in some diseases, such as cancer, the incidence and mortality rates tend to be lower among White ethnic groups in the UK compared to other groups [21–23].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [22]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W., Wu, J. C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.022 · Cited by 3,391
International Agency for Research on Cancer (IARC)
(2018) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,796
Turra, C. M., & Elo, I. T. (2008) · Population Research and Policy Review · doi:10.1007/s11113-008-9087-4 · Cited by 385
Cultural Issues in Medication Adherence: Disparities and Directions
McQuaid, E. L., & Landier, W. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4199-3 · Cited by 326
Cancer risk diversity in non-western migrants to Europe: An overview of the literature
Arnold, M., Razum, O., & Coebergh, J. W. W. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.050 · Cited by 196
The effectiveness of NHS smoking cessation services: a systematic review
Bauld, L., Bell, K., McCullough, L. B., Richardson, L., & Greaves, L. (2009) · Journal of Public Health · doi:10.1093/pubmed/fdp074 · Cited by 184
Nierkens, V., Hartman, M. A., Nicolaou, M., Vissenberg, C., Beune, E., Hosper, K., van Valkengoed, I. G. M., & Stronks, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073373 · Cited by 176
Rapid review of evaluation of interventions to improve participation in cancer screening services
Duffy, S. W., Myles, J. P., Maroni, R., & Mohammad, A. (2016) · Journal of Medical Screening · doi:10.1177/0969141316664757 · Cited by 165
Szczepura, A. K., Price, C., & Gumber, A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-346 · Cited by 158
Saunders, C. L., Abel, G., Turabi, A. E., Ahmed, F., & Lyratzopoulos, G. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002882 · Cited by 134
Cited by
Sorted by citations
Items 101–139 of 139
An internet-based survey of people with chronic lymphocytic leukemia in the UKPreprint
Lindsay, H., Yates, D., & Duley, L. (2025) · medRxiv · doi:10.1101/2025.08.05.25333089
Overcoming the Barriers to Ovarian Cancer Diagnosis and Treatment in British South Asian Communities
Morris, J. (2025) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-025-01765-z
Xin, S., Wang, T., Qi, X., Hou, L., Han, Y., & Ye, C. (2025) · ANZ Journal of Surgery · doi:10.1111/ans.70317
Calcium and Albumin Blood Tests, Ethnicity, and Cancer Incidence in Primary Care in the UK
Down, L., Barlow, M., Mounce, L. T. A., Watson, J., Merriel, S. W., Bailey, S. E. R., & Martins, T. (2025) · Cancers · doi:10.3390/cancers17172913
Prabhu, V. S., Landfeldt, E., Ralphs, E., Teoh, C., Ridsdale‐Smith, J., Macey, K. L., Trankov, N., Lambova, A., Lichfield, J., & Eminowicz, G. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70042
Mitchell, J. J., Biswas, R. K., Koemel, N. A., Ahmadi, M. N., Blodgett, J. M., Canfell, K., Lee, I.-M. M., Friedenreich, C. M., Teixeira-Pinto, A. M., Cistulli, P. A., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-05069-3
Exploring referrals to a specialist NHS cancer psychology service: a retrospective audit
Boughey, H., & Lobley, K. (2025) · Cancer Nursing Practice · doi:10.7748/cnp.2025.e1902
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.26628163
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.26628160
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2023) · Figshare · doi:10.6084/m9.figshare.24329806
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.24329941
Down, L., Barlow, M., Bailey, S. E. R., Mounce, L. T. A., Merriel, S. W., Watson, J., & Martins, T. (2024) · Figshare · doi:10.6084/m9.figshare.26685831
Mandane, B., Amirthanayagam, A., Patel, N., Darko, N., & Moss, E. L. (2024) · Figshare · doi:10.6084/m9.figshare.24634585
Talbot, A., Jebb, S. A., Foster, C., Realpe, A. X., Wheatstone, P., Buczacki, S. J. A., & Koutoukidis, D. A. (2024) · Figshare · doi:10.6084/m9.figshare.26743562
Mandane, B., Amirthanayagam, A., Patel, N., Darko, N., & Moss, E. L. (2023) · Figshare · doi:10.6084/m9.figshare.24634548
Down, L., Barlow, M., Bailey, S. E. R., Mounce, L. T. A., Merriel, S. W., Watson, J., & Martins, T. (2024) · Figshare · doi:10.6084/m9.figshare.26685837
Down, L., Barlow, M., Bailey, S. E. R., Mounce, L. T. A., Merriel, S. W., Watson, J., & Martins, T. (2024) · Figshare · doi:10.6084/m9.figshare.26685834
Deplano, Z., Cusworth, S., Doree, C. J., Griffin, J., Adderley, N. J., & Chandan, J. S. (2025) · medRxiv · doi:10.1101/2025.09.19.25336176
Improving treatment education in Black and South Asian women
Patel, A., Steventon, L., McLean, J., Nabhani‐Gebara, S., Kılıç, A., Jani, Y. H., Moon, Z., & Chambers, P. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10259-5
Experiences of Cancer and Cancer Care Amongst Ethnically Minoritised Young People in the UK
Chan, L. W., Hebben-Wadey, A., Gedara, C. K., & McParland, J. (2026) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045261422424
Barlow, M., Down, L., Mounce, L. T. A., Merriel, S. W., Watson, J., Martins, T., & Bailey, S. E. R. (2026) · medRxiv · doi:10.64898/2026.03.03.26347503
Eberhardt, J., Robb, K. A., Ahmed, F., McConnachie, A., Deidda, M., Murphy, M. K., Ashley, L., Wetherall, K., van der Graaf, P., Mireku, E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8316847/v1
Routes to cancer diagnosis for migrants in Denmark: a population-based nationwide cohort study
Dahl, A. H., Jensen, H., Falborg, A. Z., Wejse, C. M., Hvass, A. M. F., Kallestrup, P., Lyratzopoulos, G., & Virgilsen, L. F. (2026) · BMC Cancer · doi:10.1186/s12885-026-15845-2
Amoah-Arko, A. (2026) · InnovAiT Education and inspiration for general practice · doi:10.1177/17557380261446190
Dunn, J., Donnelly, P. K., Marshall, A., Elbeltagi, N. I., Hopkins, A., Ramirez, M., Thompson, A. M., Audisio, R. A., Pinder, S. E., Cameron, D., et al. (2025) · Health Technology Assessment · doi:10.3310/gjjd0722
Venables, Z. C., van Bodegraven, B., & Ahmed, S. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag183
Synesi, G., Lewis, R., Kilburn, L., Bliss, J. M., & Hall, E. (2026) · Trials · doi:10.1186/s13063-026-09812-2
High-risk prostate cancer screening – More Bang for our buck?
Ononye, R. N., Martins, T., Basu, S., Rosario, J., & Rosario, D. J. (2026) · Journal of Clinical Urology · doi:10.1177/20514158261443424
Toward personalised cancer care: AI in precision and molecular oncology
Sinha, A., Anzar, D., Owusu-Boampong, A. B., Nkrumah-Boateng, P. A., Mannan, K. M., Ali, S. H., Roy, S., & Wireko, A. A. (2026) · European journal of medical research · doi:10.1186/s40001-026-04670-9
De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study
Stephens, C., Winter, D., hawkins, M., Reulen, R. C., & Sharif, A. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03529-4
Deplano, Z., Cusworth, S., Doree, C. J., Griffin, J., Adderley, N. J., & Chandan, J. S. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111282
Almilaji, O., Walker, K., van der Meulen, J., Fearnhead, N. S., Braun, M., & Sharples, L. D. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03553-4
Martins, T., Rachet, B., Hamilton, W., & Majano, S. B. (2026) · medRxiv · doi:10.64898/2026.08.05.26359765
Anderson, A. D. G., Morgan, H., Kasaravalli, N., Guitera, P., Jurkiewicz, J., Razmara, M., & Sadeghi, M. (2026) · Skin Health and Disease · doi:10.1093/skinhd/vzag122
Dareng, E., Tran, T. N., Urbanski, H., Finch, R., Emerath, U., Kurdyukova, Y., Jison, M. L., Bahadori, L. M., Menzies-Gow, A. N., Wang, E., et al. (2026) · Pulmonary Therapy · doi:10.1007/s41030-026-00379-6
Anti-racist medicine must be on the curriculum for all healthcare professionals
Qureshi, Z. U., Suleman, M., Bamrah, J., & Graves, J. L. (2026) · BMJ · doi:10.1136/bmj-2026-100536
Sandhu, S., Oni, G., & Wilson, E. E. (2026) · International Journal of Health Promotion and Education · doi:10.1080/14635240.2026.2733132
Metadata
- Authors
- Delon, C., Brown, K. F., Payne, N. W. S., Kotrotsios, Y., Vernon, S., & Shelton, J.
- Affiliations
- Cancer Research UK (GB)
- NHS Digital (GB)
- Corresponding author
- Delon, Christine
- Venue
- British Journal of Cancer
- Published
- 2022-03-02
- Volume
- 126
- Issue
- 12
- Pages
- 1765-1773
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC9174248
- OpenAlex
- W4214903413
- Cited by
- 137
- References
- 54
- Citations by year
- 2026: 22 · 2025: 43 · 2024: 40 · 2023: 24 · 2022: 8
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- cancer incidence, ethnic disparities, ethnic minorities, Asian ethnicity, Black ethnicity, melanoma, tobacco-related cancer, prostate cancer, multiple myeloma, Hodgkin's disease, thyroid cancer, gastrointestinal cancer, lung cancer, bladder cancer, esophageal cancer, England
- MeSH terms
- Ethnicity, Gastrointestinal Neoplasms, Humans, Male, Minority Groups, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review